Le Lézard
Classified in: Science and technology

Private Cellular Networks to Generate Over US$64 Billion in Equipment Revenues by 2030

Large enterprises will drive the market for private cellular until 2030, but the mid-tier sector will be important for long-term success

LONDON, Oct. 20, 2020 /PRNewswire/ -- The immense appetite for private networks in the enterprise domain keeps rising and rising. According to new a new forecast by global tech advisory firm ABI Research, private cellular network deployments within the enterprise domain will generate equipment revenues of more than US$64 billion by 2030. While large enterprises (with annual revenues of more than US$1 billion) will drive the market for the next 10 years (accounting for 50% of private networks by 2030), enterprises with annual revenues between US$250 million and US$1 billion will account for 40% of private networks by 2030, with their proportion expected to rise further beyond the forecasting period.

ABI Research  www.abiresearch.com (PRNewsFoto/ABI Research)

"These numbers underline the huge momentum that we see for private cellular networks as a key enabler for enterprise digitization," says Leo Gergs, Research Analyst for 5G Markets at ABI Research. "As enterprises require highly customized deployment solutions, including deterministic & time sensitive networking and are governed by strict regulations regarding data protection and network integrity, the deployment of a private cellular network will be their first choice."

While large manufacturers like Bosch, Mercedes, or Siemens certainly have the financial resources and the necessary manpower to manage and operate a cellular network on their own, enterprises with annual revenues below US$1 billion do not have the resources nor capabilities to do so. Following a recent ABI Research survey among industrial manufacturers across key markets in Europe, North America, and the Asia-Pacific region, 3 out of 5 manufacturers would prefer their private network to be managed & operated by a third party.

To address this revenue opportunity within mid-tier enterprises, the telco industry needs to develop appealing offerings that take into account the business realities of these enterprises. Since enterprises with revenues of up to US$1 billion face tight budgetary constraints, large upfront investments into network deployment would serve as a true barrier to entry. "To lower this barrier and promote enterprise cellular network deployments, the telco industry needs to bid farewell to CAPEX intensive business models and develop OPEX-based offerings instead. Any such offering should adopt a service-based approach to give enterprise the reassurance of paying only for services they truly need. As a result, the telco industry should be prepared to sacrifice short-term gains for the tremendous opportunity that private cellular in the enterprise verticals domain will unlock in the long-term," Gergs advises.

The need for the telco industry to adapt is underlined by a drastic change in the shape of the competitive landscape that we are witnessing. "The traditional network operators are under attack. On the one hand, we see webscalers like Amazon Webservices (AWS) and Microsoft Azure developing End-to-End solutions for enterprise connectivity. On the other hand, we see more and more specialized network operators like Ambra, Citymesh, and Edzcom, which reserve spectrum assets to provide private cellular for enterprises as a service-based offering. Considering this, network operators need to evolve their business models fast, to protect their slice of the cake from being eaten by anyone else," concludes Gergs.

These findings are from ABI Research's Private Cellular Networks Forecast market data report. This report is part of the company's 5G Markets research service, which includes research, data, and analyst insights. Market Data spreadsheets are composed of deep data, market share analysis, and highly segmented, service-specific forecasts to provide detailed insight where opportunities lie.

About ABI Research

ABI Research provides strategic guidance to visionaries, delivering actionable intelligence on the transformative technologies that are dramatically reshaping industries, economies, and workforces across the world. ABI Research's global team of analysts publish groundbreaking studies often years ahead of other technology advisory firms, empowering our clients to stay ahead of their markets and their competitors. 

ABI Research???????????????????????????? ?1990???????????????????????????????????????????????????? ???????????????? 

For more information about ABI Research's services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.

Contact Info
Deborah Petrara                                                           
Tel: +1.516.624.2558                                                    

Logo - https://mma.prnewswire.com/media/276887/abi_research_logo.jpg


These press releases may also interest you

at 21:00
100x Group, the holding group for HDR Global Trading Limited, owner and operator of the BitMEX platform, has appointed Alexander Höptner as its new Chief Executive Officer.   Höptner will lead 100x Group as they pursue their vision of shaping the...

at 20:50
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew...

at 20:45
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq.WeissLaw LLP1500 Broadway, 16th FloorNew...

at 20:35
Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of heart failure (hereinafter HF), today announced that they have been named 2020 Healthcare Company of the...

at 20:25
In June 2020, a consortium has been initiated by InnoStudio Inc. (HU) for the development and validation of highly efficient active compounds against SARS-CoV-2 while conducting drug discovery simultaneously and in a synchronized manner in space and...

at 20:25
Reliq Health Technologies Inc. ("Reliq" or the "Company"), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare announced that the interim consolidated financial...

News published on 20 october 2020 at 04:00 and distributed by: